A detailed history of F transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, F holds 45,778 shares of AKRO stock, worth $2.25 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
45,778
Holding current value
$2.25 Million
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$26.75 - $35.28 $1.22 Million - $1.62 Million
45,778 New
45,778 $1.27 Million

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.29B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track F Portfolio

Follow F and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F, based on Form 13F filings with the SEC.

News

Stay updated on F with notifications on news.